Surf Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSurf Bio
Surf Bio logo

Surf Bio

0 followers

About Surf Bio

Surf Bio is a preclinical biopharmaceutical company focused on transforming delivery of antibodies and biologics. Its Surf SnapShot technology enables ultra-high concentration formulations and subcutaneous injections, allowing rapid dosing and at-home administration for therapies in areas such as diabetes, oncology, HIV, and COVID-19. The company aims to replace traditional IV infusions with simple, standard autoinjector shots, broadening patient access to high-dose biologics. Founded in 2021 by the founders of Bigfoot Biomedical and Mode AGC, Surf Bio combines polymer-based excipients with delivery innovations to enhance stability and patient convenience, and operates globally in the biotherapeutics space.

Recent News

Recent Deals

Key Team Members

Bryan Mazlish

Chief Executive Officer

Jennifer Schneider, MD

President & Chief Medical Officer

Eric Appel, PhD

Chief Scientific Advisor

Doug Hecker

Head of Technical Operations

Key Facts

HQ Location

Palo Alto, United States

Employees

1 - 10

Status

Private

Website

https://surf.bio